These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 972445)

  • 1. Effect of dialysate calcium concentration on bone disease in patients on hemodialysis.
    Regan RJ; Peacock M; Rosen SM; Robinson PJ; Horsman A
    Kidney Int; 1976 Sep; 10(3):246-55. PubMed ID: 972445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of high dialysate calcium concentration on bone remodelling, serum biochemistry, and parathyroid hormone in patients with renal osteodystrophy.
    Drüeke T; Bordier PJ; Man NK; Jungers P; Marie P
    Kidney Int; 1977 Apr; 11(4):267-74. PubMed ID: 857076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between different dialysate calcium concentrations in nocturnal hemodialysis.
    Toussaint ND; Polkinghorne KR; Kerr PG; Somerville CA; Agar JW
    Hemodial Int; 2007 Apr; 11(2):217-24. PubMed ID: 17403174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Lowering Dialysate Calcium Concentration on Mineral and Bone Disorders in Chronic Hemodialysis Patients: Conversion from 3.0 mEq/L to 2.75 mEq/L.
    Yamada S; Ueki K; Tokumoto M; Suehiro T; Kimura H; Taniguchi M; Fujimi S; Kitazono T; Tsuruya K
    Ther Apher Dial; 2016 Feb; 20(1):31-9. PubMed ID: 26482334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of dialysate Ca concentrations on the therapeutic effects of etelcalcetide with concomitant drugs in patients with secondary hyperparathyroidism.
    Shigematsu T; Fukagawa M; Yokoyama K; Akiba T; Fujii A; Shinoda A; Akizawa T
    Nephrology (Carlton); 2020 Aug; 25(8):634-643. PubMed ID: 31765028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.
    Bielesz BO; Hecking M; Plischke M; Cejka D; Kieweg H; Haas M; Marculescu R; Hörl WH; Bieglmayer C; Sunder-Plassmann G
    Clin Biochem; 2014 Sep; 47(13-14):1316-9. PubMed ID: 24956265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of lowering dialysate calcium concentration on mineral metabolism and hemodynamic parameters in hemodialysis patients.
    Alayoud A; El Kabbaj D; Benyahia M; Asseraji M; Zemraoui N
    Iran J Kidney Dis; 2015 Mar; 9(2):132-7. PubMed ID: 25851292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of CAPD and hemodialysis on parathyroid function.
    Malberti F; Corradi B; Imbasciati E
    Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Lowering Dialysate Calcium Concentration on Bone Metabolic Markers in Hemodialysis Patients With Suppressed Serum Parathyroid Hormone: A Preliminary Study.
    Niwa H; Fukasawa H; Ishibuchi K; Kaneko M; Yasuda H; Furuya R
    Ther Apher Dial; 2018 Oct; 22(5):503-508. PubMed ID: 29923680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of salmon calcitonin on bone mineral density and calcium-phosphate metabolism in chronic hemodialysis patients with secondary hyperparathyroidism].
    Matuszkiewicz-Rowińska J; Niemczyk S; Przedlacki J; Puka J; Switalski M; Ostrowski K
    Pol Arch Med Wewn; 2004 Jul; 112(1):797-803. PubMed ID: 15526839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of dialysate calcium on the therapeutic effects of sevelamer hydrochloride in hemodialysis patients with secondary hyperparathyroidism under treatment of intravenous vitamin d metabolites.
    Ando R; Naito S; Inagaki Y; Hata T; Ishida Y; Chida Y; Takayama M; Tachibana K; Ohtsuka M; Inoue A
    Ther Apher Dial; 2005 Feb; 9(1):16-23. PubMed ID: 15828901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteocalcin, iPTH, alkaline phosphatase and hand X-ray scores as predictive indices of histomorphometric parameters in renal osteodystrophy.
    Mazzaferro S; Coen G; Ballanti P; Bondatti F; Bonucci E; Pasquali M; Sardella D; Tomei E; Taggi F
    Nephron; 1990; 56(3):261-6. PubMed ID: 2077408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimum dialysate calcium concentration during maintenance hemodialysis.
    Johnson WJ
    Nephron; 1976; 17(4):241-58. PubMed ID: 951012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical benefit of the change of dialysate calcium concentration from 3.0 to 2.75 mEq/L.
    Sakai Y; Otsuka T; Ohno D; Murasawa T; Sakai S; Tsuruoka S
    Ther Apher Dial; 2014 Apr; 18(2):181-4. PubMed ID: 24720409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualization of dialysate calcium concentration according to baseline pre-dialysis serum calcium.
    Gonzalez-Parra E; Gonzalez-Casaus ML; Arenas MD; Sainz-Prestel V; Gonzalez-Espinoza L; Muñoz-Rodriguez MA; Tabikh A; Egido J; Ortiz A
    Blood Purif; 2014; 38(3-4):224-33. PubMed ID: 25531119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal osteodystrophy and metastatic calcification in long-term continuous ambulatory peritoneal dialysis.
    Cassidy MJ; Owen JP; Ellis HA; Dewar J; Robinson CJ; Wilkinson R; Ward MK; Kerr DN
    Q J Med; 1985 Jan; 54(213):29-48. PubMed ID: 3975345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nocturnal but not short hours quotidian hemodialysis requires an elevated dialysate calcium concentration.
    Al-Hejaili F; Kortas C; Leitch R; Heidenheim AP; Clement L; Nesrallah G; Lindsay RM
    J Am Soc Nephrol; 2003 Sep; 14(9):2322-8. PubMed ID: 12937309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary hyperparathyroidism in patients on maintenance hemodialysis: study of the N and C-terminal parathyroid hormones.
    Hida M; Shimbo T; Nakamura K; Wakabayashi T; Saitoh H; Satoh T
    Tokai J Exp Clin Med; 1983 Jul; 8(3):225-8. PubMed ID: 6670108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term treatment of secondary hyperparathyroidism in the chronic hemodialysis patient with 1,25-(OH)2D3].
    Giachino G; Giacchino F; Jeantet A; Del Piano A; Garetto A; Pellerey M; Piccoli G
    Minerva Med; 1985 Mar; 76(9-10):407-14. PubMed ID: 2984605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.